DUBLIN, Feb. 20, 2023 (GLOBE NEWSWIRE) — Innovation Zed, an Irish R&D firm specialising within the design, improvement and manufacturing of medical applied sciences, introduced in the present day it has secured a CE Mark for the InsulCheck DOSE add-on system. As a pacesetter in linked and sensible drug supply applied sciences, this certification showcases our dedication to assembly related well being, security, and environmental necessities relating to shopper security within the European Union (EU). It additionally opens the door for business enlargement inside Europe for the rising firm.
InsulCheck DOSE is a single-unit add-on system for pen injectors that routinely captures dose worth dialled, injection occasion time stamp and temperature in addition to mounting and unmounting occasions. With InsulCheck DOSE, real-time injection occasion knowledge are logged and despatched routinely to a suitable show system. Product highlights embody:
- A discreet add-on system suitable with all pen-injectors
- Captures dose dialled, timestamp, ambient temperature, and so on.
- A handy system with no buttons, no calibration necessities or interference with the traditional injection course of
- Elevated person engagement via high-quality usability assist options from a vibrant OLED display screen
Innovation Zed is devoted to serving to insulin pen customers inside the diabetes inhabitants. Given our understanding of the challenges confronted by insulin pen customers worldwide, our focus is to assist all insulin pen customers no matter their injection pen of selection. On account of a collaboration with our accomplice SHL Medical and its subsidiary SHL Applied sciences, InsulCheck DOSE has been developed to fulfill the compatibility challenges introduced by varied injection pen designs and particularly the difficulties in engaged on a expertise to reliably and precisely assist low-cost disposable pens.
Dr Dean Minnock, CEO of Innovation Zed, stated, “InsulCheck DOSE is a third-generation product of the InsulCheck household and probably the most clever and suitable evolution of the InsulCheck platform. InsulCheck DOSE offers knowledge that, when utilized accurately, facilitates an evidence-driven method to precision insulin administration and considerably helps folks with diabetes make extra knowledgeable decisions for his or her private remedy plan. Our InsulCheck DOSE helps all insulin pens with out altering the usability of the pen in any method and with out interfering within the regular injection course of. In securing the CE mark for InsulCheck DOSE we reached an unimaginable milestone for our firm and for folks dwelling with diabetes in Europe.”
Innovation Zed expects to provoke a business launch of InsulCheck DOSE in Europe throughout 2023. The corporate additionally has plans to introduce bespoke variations of InsulCheck DOSE to new injection gadgets for varied drug therapies over the approaching years.
About Innovation Zed
Innovation Zed, Ltd. empowers folks to take management of diabetes via linked expertise for insulin injection pens. Headquartered in Dublin, Eire, Innovation Zed has emerged as a pacesetter in injection pen expertise. By listening to the wants of customers, caregivers, and suppliers, Innovation Zed simplifies and improves diabetes administration all over the world. For extra details about InsulCheck DOSE go to www.innovationzed.com.
Contact Data:
Andrew Fitzpatrick
Analysis and Improvements Supervisor
[email protected]
Dean Minnock
CEO
[email protected]
Associated Photographs
Picture 1: InsulCheck DOSE by Innovation Zed
InsulCheck DOSE routinely captures dose dialled and time since final injection
This content material was issued via the press launch distribution service at Newswire.com.
- InsulCheck DOSE by Innovation Zed